India Develops Placenta-on-Chip
Analysis based on 8 articles · First reported Jul 04, 2026 · Last updated Jul 04, 2026
The development of the placenta-on-chip technology by India — ICMR-National Institute for Research in Reproductive Health and IIT Bombay is expected to positively impact the biotechnology and pharmaceutical industries by providing a more efficient and ethical platform for drug testing and understanding pregnancy complications. This could lead to faster development of safer medications for pregnant women and improved maternal and fetal health outcomes, potentially reducing costs associated with animal testing.
Indian scientists from India — ICMR-National Institute for Research in Reproductive Health and IIT Bombay have developed a groundbreaking 'placenta-on-chip' technology. This lab-grown model replicates key functions of the human placenta, offering a novel platform to study pregnancy, understand complications like gestational diabetes, and evaluate drug safety. The simple, scalable design aims for widespread adoption in research, potentially reducing reliance on animal testing. Key figures like Deepak Modi, Anshul Bhide, and Abhijit Majumdar were instrumental in its development and validation. This innovation strengthens India's capabilities in biomedical research and aligns with global efforts for human-relevant research models.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard